Document is current
Any future updates will be listed below
-
Authors
Seki, Shu-Ichi https://orcid.org/0009-0000-1498-4408
Soga, Yoshimitsu
Iida, Osamu
Kawasaki, Daizo
Anzai, Hitoshi
Ando, Hiroshi
Nakama, Tatsuya
Shinozaki, Norihiko
Kozuki, Amane
Ishihara, Masaharu
Urasawa, Kazushi
Hayashi, Fumiyuki
Tsujita, Hiroaki
Tobita, Kazuki
Ogata, Kenji
Horie, Kazunori
Hayakawa, Naoki
Mori, Shinsuke
Fujihara, Masahiko
Ohki, Takao
Yuba, Kenichiro
Mano, Toshiaki
Nakamura, Masato
,
- License Information
-
More Information
Article History
Received: 28 January 2026
Accepted: 20 April 2026
First Online: 24 April 2026
Declarations
:
: The trial was conducted in accordance with the Declaration of Helsinki, good clinical practice guidelines, and applicable laws as specified by all relevant governmental authorities. IRB approval was obtained at all participating sites. The complete list of IRBs was provided in the supplementary material.
: Informed consent was obtained from all individual participants included in the study. Consent for publication was obtained for every individual person’s data included in the study.
: Informed consent for publication was obtained from all individual participants included in the study.
: The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article.Y. Soga, O. Iida, Y. Kawasaki, T. Nakama, N. Shinozaki, K. Urasawa, M. Nakamura, H. Tsujita, K. Tobita, K. Horie, M. Fujihara, and T. Ohki are consultants who received honoraria from TERUMO CORPORATION.S. Seki, Y. Soga, O. Iida, D. Kawasaki, H. Anzai, H. Ando, T. Nakama, N. Shinozaki, A. Kozuki, K. Urasawa, M. Nakamura, H. Tsujita, K. Tobita, K. Ogata, K. Horie, N. Hayakawa, S. Mori, M. Fujihara, T. Ohki and K. Ando received honoraria from TERUMO CORPORATION.T. Mano, M. Ishihara, S. Toi, K. Yuba, and F. Hayashi have no conflicts of interest to report.
